APP and Alzheimer disease: Increasing lines of evidence have implicated the possible impacts of SARS-CoV-2 infection on AD-like pathologies [22, 24–26], including the increased amyloid precursor protein (APP) expression [27, 28], exacerbated β-amyloid (Aβ) pathology [29], and elevated serum level of phosphorylated tau [30].